Clinical Trials Directory

Trials / Terminated

TerminatedNCT00891995

Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes

Status
Terminated
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
71 (actual)
Sponsor
Jaeb Center for Health Research · Academic / Other
Sex
All
Age
6 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out if very tight blood glucose control from the onset of Type 1 Diabetes can preserve beta cell function. Study subjects will be randomly assigned to receive either standard diabetes management or intensive diabetes management, which involves several days of closed loop therapy followed by home use of a continuous glucose monitor and insulin pump.

Detailed description

The specific aim of this study is to determine if early restoration of metabolic control will improve C-peptide production compared to children receiving routine diabetes management and the secondary aim is to determine if allowing the islet cells to be less metabolically active will have an impact on the underlying autoimmune process. Following completion of the baseline procedures (Mixed Meal Tolerance Test and blood sample collection), participants are randomized to either the Standard Treatment Group or the Intensive Treatment Group which includes 4-6 days of inpatient closed loop therapy followed by outpatient use of an insulin pump and continuous glucose monitor for diabetes management. All subjects will be seen 7 times in the first year and 4 times in the second year for follow-up testing. Subjects who are still producing insulin after 2 years may be asked to return every 6 months for an additional 2 years.

Conditions

Interventions

TypeNameDescription
DEVICEClosed loopClosed loop therapy for up to 4 to 6 days
DEVICEHome glucose monitoringStandard diabetes management using a home glucose meter.
DEVICEInsulin pumpInsulin pump use for 2 years
DEVICEContinuous glucose monitorContinuous glucose monitor use for 2 years

Timeline

Start date
2010-09-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2009-05-01
Last updated
2016-12-30
Results posted
2016-10-27

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00891995. Inclusion in this directory is not an endorsement.